NCT00611598 - DNA Repair and Genetic Susceptibility to Lung Cancer | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

February 11, 2003

Primary Completion Date

March 24, 2023

Study Completion Date

March 24, 2023

Conditions

Lung CancerSingle Primary Lung CancerSecond Primary Lung Cancer

Interventions

OTHER

Blood draw and Questionnaires

Pt will have three green top tubes of blood drawn. The questionnaire will be filled out by the study subject. This may be completed at home and mailed in a provided stamped addressed envelope if the patient prefer, or obtained by phone interview with a research assistant.

OTHER

Blood draw and Questionnaires

Pt will have three green top tubes of blood drawn. The questionnaire will be filled out by the study subject. This may be completed at home and mailed in a provided stamped addressed envelope if the patient prefer, or obtained by phone interview with a research assistant.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York